AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33086238 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD5213 + pregabalin
Number of subjects: 0
Study 33086238 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 0
Study 33086238 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33679615 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate FET during the first menstrual cycle after a failed fresh ET cycle
Number of subjects: 732
Study 33679615 — intervention group
Group type: COMPARATOR
Intervention: Delayed FET during the second menstrual cycle after a failed fresh ET cycle
Number of subjects: 732
Study 32043766 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical resection
Number of subjects: 2004
Study 32043766 — intervention group
Group type: COMPARATOR
Intervention: Active surveillance
Number of subjects: 2004
Study 33111359 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous exercise (20-min cycling bout) after sleep restriction (RES)
Number of subjects: 9
Study 33111359 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous exercise (20-min cycling bout) after sleep fragmentation (FRAG)
Number of subjects: 9
Study 33111359 — intervention group
Group type: COMPARATOR
Intervention: Control (normal sleep)
Number of subjects: 9
Study 35565786 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-AGE diet (n = 20)
Number of subjects: 40
Study 35565786 — intervention group
Group type: COMPARATOR
Intervention: Regular diabetic diet (n = 20)
Number of subjects: 40
Study 35565786 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-AGE diet
Number of subjects: 40
Study 35565786 — intervention group
Group type: COMPARATOR
Intervention: Regular diabetic diet
Number of subjects: 40
Study 32048028 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) applied after septoplasty
Number of subjects: 148
Study 32048028 — intervention group
Group type: COMPARATOR
Intervention: Non-PRF (control group)
Number of subjects: 148
Study 32048028 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF)
Number of subjects: 148
Study 34815219 — intervention group
Group type: EXPERIMENTAL
Intervention: Risankizumab 150 mg
Number of subjects: 444
Study 34815219 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 444
Study 33141936 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-trigger transfusion (haemoglobin below 8.0 g/dL)
Number of subjects: 46
Study 33141936 — intervention group
Group type: COMPARATOR
Intervention: High-trigger transfusion (haemoglobin below 9.7 g/dL)
Number of subjects: 46
Study 34568637 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced E‐cigarette Coaching (EEC)
Number of subjects: 96
Study 34568637 — intervention group
Group type: COMPARATOR
Intervention: Quitline treatment as usual (TAU)
Number of subjects: 96
Study 33744844 — intervention group
Group type: EXPERIMENTAL
Intervention: Health IT intervention using the Patient Buddy app focusing on ascites, medications, and hepatic encephalopathy over 30 days.
Number of subjects: 349
Study 34792188 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) with Dermatophagoides farinae drops
Number of subjects: 440
Study 34792188 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (topical glucocorticoids, skin moisturizers, oral antihistamines, allergen avoidance)
Number of subjects: 440
Study 34309241 — intervention group
Group type: EXPERIMENTAL
Intervention: HD201
Number of subjects: 105
Study 34309241 — intervention group
Group type: COMPARATOR
Intervention: EU-Herceptin®
Number of subjects: 105
Study 34309241 — intervention group
Group type: COMPARATOR
Intervention: US-Herceptin®
Number of subjects: 105
Study 32551817 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning classifier models using readily available clinical data
Number of subjects: 2747
Study 32551817 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperinflammatory phenotype as classified by the model
Number of subjects: 2747
Study 32551817 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning models
Number of subjects: 2747
Study 32551817 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical classifier model-assigned phenotypes
Number of subjects: 2747
Study 34710894 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual Metacognitive Interpersonal Therapy (MIT) combined with Group Mentalization-Based Treatment (MBT)
Number of subjects: 30
Study 32948472 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity multifaceted antimicrobial stewardship intervention
Number of subjects: 167
Study 32652388 — intervention group
Group type: EXPERIMENTAL
Intervention: Cue-reactivity paradigm with shopping-related pictures
Number of subjects: 277
Study 32652388 — intervention group
Group type: EXPERIMENTAL
Intervention: Craving measurement before and after the cue-reactivity paradigm
Number of subjects: 277
Study 32652388 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual dot probe paradigm, implicit association test, affective shifting task
Number of subjects: 277
Study 36084129 — intervention group
Group type: EXPERIMENTAL
Intervention: Cultural adaptation promotion resilience program (CAPRP), performed for 60 minutes, twice a week for four weeks
Number of subjects: 42
Study 34876965 — intervention group
Group type: COMPARATOR
Intervention: Drainage skin-bridge sparing surgery combined with fistulotomy (CG)
Number of subjects: 125
Study 34876965 — intervention group
Group type: EXPERIMENTAL
Intervention: Fistulotomy only (OG)
Number of subjects: 125
Study 32124462 — intervention group
Group type: EXPERIMENTAL
Intervention: Learned pacing intervention
Number of subjects: 12
Study 32124462 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 12
Study 33632576 — intervention group
Group type: EXPERIMENTAL
Intervention: Barrier group (extraction, barrier, and suture)
Number of subjects: 30
Study 33632576 — intervention group
Group type: COMPARATOR
Intervention: Control group (extraction and suture)
Number of subjects: 30
Study 33125944 — intervention group
Group type: EXPERIMENTAL
Intervention: IMRT with cetuximab and avelumab (10 mg/kg day 7 and every 2 weeks) followed by avelumab every two weeks for 12 months (arm B and C)
Number of subjects: 82
Study 33125944 — intervention group
Group type: EXPERIMENTAL
Intervention: IMRT with cetuximab and avelumab (arm B and C)
Number of subjects: 82
Study 33125944 — intervention group
Group type: COMPARATOR
Intervention: Intensity Modulated Radiation Therapy (IMRT) with cisplatin (100 mg/m2 Q3W) (arm A)
Number of subjects: 82
Study 33125944 — intervention group
Group type: COMPARATOR
Intervention: Intensity Modulated Radiation Therapy (IMRT) with weekly cetuximab (arm D)
Number of subjects: 82
Study 36251291 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent facilitation
Number of subjects: 3647
Study 33693757 — intervention group
Group type: EXPERIMENTAL
Intervention: Preconception micronutrient supplementation
Number of subjects: 5011
Study 33326576 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV-vaccine arm
Number of subjects: 2153
Study 35964211 — intervention group
Group type: EXPERIMENTAL
Intervention: CIMT-LE
Number of subjects: 38
Study 35964211 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 38
Study 34110960 — intervention group
Group type: EXPERIMENTAL
Intervention: BFR-LIX
Number of subjects: 32
Study 34110960 — intervention group
Group type: COMPARATOR
Intervention: Acute occlusion
Number of subjects: 32
Study 35246005 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicon (Si) application
Number of subjects: 0
Study 35246005 — intervention group
Group type: COMPARATOR
Intervention: Lead (Pb) application
Number of subjects: 0
Study 35246005 — intervention group
Group type: COMPARATOR
Intervention: Cadmium (Cd) application
Number of subjects: 0
Study 35246005 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 32991946 — intervention group
Group type: EXPERIMENTAL
Intervention: Personality-targeted motivational interviewing intervention
Number of subjects: 52
Study 32991946 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 52
Study 36042627 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein (10 g/d) with resistance training (3 times a week)
Number of subjects: 45
Study 36042627 — intervention group
Group type: COMPARATOR
Intervention: Placebo (10 g/d) with resistance training (3 times a week)
Number of subjects: 45
Study 36042627 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (RT+WP and RT+placebo)
Number of subjects: 45
Study 32940689 — intervention group
Group type: EXPERIMENTAL
Intervention: Palbociclib plus fulvestrant
Number of subjects: 459
Study 32940689 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus fulvestrant
Number of subjects: 459
Study 32940689 — intervention group
Group type: EXPERIMENTAL
Intervention: High circulating tumor fraction
Number of subjects: 459
Study 32940689 — intervention group
Group type: EXPERIMENTAL
Intervention: TP53 mutation
Number of subjects: 459
Study 32940689 — intervention group
Group type: EXPERIMENTAL
Intervention: FGFR1 amplification
Number of subjects: 459
Study 35658926 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 90
Study 35658926 — intervention group
Group type: EXPERIMENTAL
Intervention: Yi Jin Jing
Number of subjects: 90
Study 35658926 — intervention group
Group type: COMPARATOR
Intervention: Combined oral contraceptives (Control)
Number of subjects: 90
Study 32062521 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week exercise training intervention
Number of subjects: 22
Study 32062521 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 22
Study 34913959 — intervention group
Group type: EXPERIMENTAL
Intervention: Apatinib 500 mg/d
Number of subjects: 92
Study 34913959 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study 33289973 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (800 mg once, followed by 400 mg daily for 6 days)
Number of subjects: 2314
Study 33289973 — intervention group
Group type: COMPARATOR
Intervention: Usual care (no specific therapy)
Number of subjects: 2314
Study 33289973 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 2314
Study 33289973 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2314
Study 32243574 — intervention group
Group type: EXPERIMENTAL
Intervention: O-R electric toothbrush with micro-vibrations
Number of subjects: 27
Study 32243574 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 27
Study 35982468 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised instant messaging (PIM)
Number of subjects: 1200
Study 35982468 — intervention group
Group type: COMPARATOR
Intervention: Regular instant messaging (RIM)
Number of subjects: 1200
Study 35982468 — intervention group
Group type: EXPERIMENTAL
Intervention: Optional combined interventions (multi-media messages, nicotine replacement therapy sampling, financial incentive for active referral, phone counselling, and family/peer support group chat)
Number of subjects: 1200
Study 35982468 — intervention group
Group type: EXPERIMENTAL
Intervention: Continued-PIM
Number of subjects: 1200
Study 35982468 — intervention group
Group type: EXPERIMENTAL
Intervention: PIM
Number of subjects: 1200
Study 35982468 — intervention group
Group type: EXPERIMENTAL
Intervention: Continued-RIM
Number of subjects: 1200
Study 33103916 — intervention group
Group type: EXPERIMENTAL
Intervention: Gait training using a peroneal nerve stimulation device
Number of subjects: 119
Study 33103916 — intervention group
Group type: COMPARATOR
Intervention: Gait training without the device (control)
Number of subjects: 119
Study 32350792 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-vitamin K oral anticoagulants (NOACs) such as apixaban and edoxaban
Number of subjects: 40
Study 32350792 — intervention group
Group type: COMPARATOR
Intervention: Vitamin K antagonists (VKA)
Number of subjects: 40
Study 35848873 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-1343-5p
Number of subjects: 126
Study 35848873 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-6087
Number of subjects: 126
Study 35848873 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum levels of identified miRNAs
Number of subjects: 126
Study 32901243 — intervention group
Group type: EXPERIMENTAL
Intervention: Desensitizing-containing hydrogen peroxide gel (5% potassium nitrate)
Number of subjects: 60
Study 32901243 — intervention group
Group type: COMPARATOR
Intervention: Desensitizing-free hydrogen peroxide gel (35%)
Number of subjects: 60
Study 33842864 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid-test-guided treatment for ASB
Number of subjects: 240
Study 33842864 — intervention group
Group type: COMPARATOR
Intervention: Usual hospital-care (Control)
Number of subjects: 240
Study 32445190 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg Δ9-THC
Number of subjects: 27
Study 32445190 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg Δ9-THC
Number of subjects: 27
Study 32445190 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 35855512 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-second chair stand test (30CST)
Number of subjects: 81
Study 35855512 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral step-up test (LSUT)
Number of subjects: 81
Study 35855512 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified lateral step-up test (MLSUT)
Number of subjects: 81
Study 35855512 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 times sit to stand (5×STS)
Number of subjects: 81
Study 33168942 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (IPC) - 3 × 5 min ischemia/reperfusion
Number of subjects: 22
Study 33168942 — intervention group
Group type: COMPARATOR
Intervention: Mock IPC
Number of subjects: 22
Study 33168942 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote IPC
Number of subjects: 22
Study 33168942 — intervention group
Group type: COMPARATOR
Intervention: Endothelial ischemia-reperfusion (I/R) injury
Number of subjects: 22
Study 32004693 — intervention group
Group type: EXPERIMENTAL
Intervention: Vi-DT Typhoid Conjugate Vaccine
Number of subjects: 200
Study 32004693 — intervention group
Group type: COMPARATOR
Intervention: Inactivated poliovirus vaccine
Number of subjects: 200
Study 35676445 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal deep learning architecture for therapy personalization
Number of subjects: 7764
Study 35676445 — intervention group
Group type: COMPARATOR
Intervention: NCCN risk groups (control)
Number of subjects: 7764
Study 33601698 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidimensional Assessment of Interoceptive Awareness (MAIA) - body trusting
Number of subjects: 281
Study 33601698 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidimensional Assessment of Interoceptive Awareness (MAIA) - body listening
Number of subjects: 281
Study 33601698 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidimensional Assessment of Interoceptive Awareness (MAIA) - noticing
Number of subjects: 281
Study 33601698 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidimensional Assessment of Interoceptive Awareness (MAIA) - emotional awareness
Number of subjects: 281
Study 33601698 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidimensional Assessment of Interoceptive Awareness (MAIA) - self-regulation
Number of subjects: 281
Study 35500415 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative pedagogy of geriatric care course for 18 weeks, 2 hours per week
Number of subjects: 87
Study 35500415 — intervention group
Group type: COMPARATOR
Intervention: General lectures (Control group)
Number of subjects: 87
Study 34184426 — intervention group
Group type: EXPERIMENTAL
Intervention: AET
Number of subjects: 42
Study 34184426 — intervention group
Group type: EXPERIMENTAL
Intervention: IMT + AET
Number of subjects: 42
Study 34184426 — intervention group
Group type: EXPERIMENTAL
Intervention: IMT
Number of subjects: 42
Study 34184426 — intervention group
Group type: COMPARATOR
Intervention: NT
Number of subjects: 42
Study 32033913 — intervention group
Group type: EXPERIMENTAL
Intervention: Random Forest + Classifier Attribute Evaluation (RF+CLAE)
Number of subjects: 147
Study 32033913 — intervention group
Group type: EXPERIMENTAL
Intervention: Random Forest + One Rule Attribute Evaluation (RF+ORAE)
Number of subjects: 147
Study 32033913 — intervention group
Group type: EXPERIMENTAL
Intervention: Random Committee + One Rule Attribute Evaluation (RC+ORAE)
Number of subjects: 147
Study 32033913 — intervention group
Group type: EXPERIMENTAL
Intervention: Random Forest + Principal Components Analysis (RF+PRCA)
Number of subjects: 147
Study 32033913 — intervention group
Group type: EXPERIMENTAL
Intervention: Logit-Boost + Principal Components Analysis (LB+PRCA)
Number of subjects: 147
Study 35704556 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary medical male circumcision (VMMC)
Number of subjects: 6416
Study 35704556 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral from HIV testing services
Number of subjects: 6416
Study 35704556 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral acceptance
Number of subjects: 6416
Study 35704556 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic factors
Number of subjects: 6416
Study 35704556 — intervention group
Group type: EXPERIMENTAL
Intervention: Reasons for not being circumcised
Number of subjects: 6416
Study 33784987 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung-protective ventilation (LPV) with a tidal volume (Vt) of 7 ml kg−1 ideal body weight (IBW), 10 cmH2O positive end-expiratory pressure (PEEP) combined with regular recruitment maneuvers (RMs)
Number of subjects: 62
Study 33784987 — intervention group
Group type: COMPARATOR
Intervention: Conventional ventilation (CV) with a Vt of 10 ml kg−1 IBW, 0 cmH2O in PEEP and no RMs
Number of subjects: 62
Study 33128399 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Papilla Preservation Technique (mPPT)
Number of subjects: 44
Study 33128399 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination with Autogenous Bone Grafts (AG)
Number of subjects: 44
Study 33128399 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of mPPT and AG
Number of subjects: 44
Study 33128399 — intervention group
Group type: COMPARATOR
Intervention: rhFGF-2 therapy
Number of subjects: 44
Study 35980309 — intervention group
Group type: EXPERIMENTAL
Intervention: CDC HEADS UP handouts
Number of subjects: 0
Study 35980309 — intervention group
Group type: COMPARATOR
Intervention: Education as usual
Number of subjects: 0
Study 32827404 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Guided Imagery (BGI)
Number of subjects: 37
Study 32827404 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 37
Study 35594703 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib with green tea extract (GTE)
Number of subjects: 26
Study 35594703 — intervention group
Group type: COMPARATOR
Intervention: Nintedanib alone
Number of subjects: 26
Study 32562575 — intervention group
Group type: EXPERIMENTAL
Intervention: Emollient with basic pH 8.5
Number of subjects: 12
Study 32562575 — intervention group
Group type: EXPERIMENTAL
Intervention: Emollient with pH 5.5
Number of subjects: 12
Study 32562575 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline S. aureus frequency
Number of subjects: 12
Study 32562575 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (HE)
Number of subjects: 12
Study 33952529 — intervention group
Group type: EXPERIMENTAL
Intervention: HepCATT intervention
Number of subjects: 0
Study 33952529 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 32363638 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin (GBP) 100 mg/day orally for 6 weeks
Number of subjects: 32
Study 32363638 — intervention group
Group type: COMPARATOR
Intervention: Hydroxyzine (HYDZ) 25 mg/day orally for 6 weeks
Number of subjects: 32
Study 36362612 — intervention group
Group type: EXPERIMENTAL
Intervention: Perineural catheter with ropivacaine infiltration (ROPI)
Number of subjects: 56
Study 36362612 — intervention group
Group type: COMPARATOR
Intervention: Systemic analgesia (CONTROL)
Number of subjects: 56
Study 32526490 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholic beer (BAC = 0.06)
Number of subjects: 125
Study 32526490 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholic beer (BAC = 0.03)
Number of subjects: 125
Study 32526490 — intervention group
Group type: COMPARATOR
Intervention: Non-alcoholic beer (placebo-control group)
Number of subjects: 125
Study 34120463 — intervention group
Group type: EXPERIMENTAL
Intervention: Cream with lipid nanoparticles and vitamin E (Group A)
Number of subjects: 108
Study 34120463 — intervention group
Group type: COMPARATOR
Intervention: Cream without nanoparticles nor vitamin E (Group B)
Number of subjects: 108
Study 34120463 — intervention group
Group type: COMPARATOR
Intervention: Cream with nanoparticles without vitamin E (Group C)
Number of subjects: 108
Study 34120463 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 108
Study 33541495 — intervention group
Group type: EXPERIMENTAL
Intervention: rhTPO 15,000 U, once daily for 7 days
Number of subjects: 100
Study 33541495 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine treatment)
Number of subjects: 100
Study 34407729 — intervention group
Group type: EXPERIMENTAL
Intervention: Kojic acid combined with fractional Er:YAG laser
Number of subjects: 25
Study 34407729 — intervention group
Group type: COMPARATOR
Intervention: Kojic acid alone
Number of subjects: 25
Study 32337693 — intervention group
Group type: EXPERIMENTAL
Intervention: Sheng Xue Ning (SXN) tablets
Number of subjects: 94
Study 32337693 — intervention group
Group type: COMPARATOR
Intervention: Ferrous succinate (FS) tablets
Number of subjects: 94
Study 34397819 — intervention group
Group type: EXPERIMENTAL
Intervention: Group I (chronic periodontitis with smoking and stress)
Number of subjects: 600
Study 34397819 — intervention group
Group type: EXPERIMENTAL
Intervention: Group II (chronic periodontitis without smoking and stress)
Number of subjects: 600
Study 34397819 — intervention group
Group type: COMPARATOR
Intervention: Group III (control group, healthy subjects)
Number of subjects: 600
Study 33050179 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Therapeutic Exercise Programme (PTE) added to Family Caregiver Care Programme (FCCP)
Number of subjects: 68
Study 36026657 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Resistance Exercise (DRE)
Number of subjects: 70
Study 36026657 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Resistance Exercise (CRE)
Number of subjects: 70